Dyal Capital Partners, a unit of Blue Owl, specializes in acquiring minority equity interests in institutional alternative asset management businesses worldwide. The firm focuses on private equity investments, typically targeting established asset managers across various sectors and geographies.

Notable portfolio companies include Silver Lake, BridgeBio Pharma, and 6sense. Dyal Capital Partners offers unique value to its portfolio by providing strategic capital and operational expertise to help alternative asset managers grow and scale their businesses. The firm's approach combines deep industry knowledge with a long-term investment philosophy, aiming to create lasting partnerships with leading alternative investment firms.

Concentration shown as share of disclosed investments by stage.